Latest Commercialization News

xReality Group delivered a standout Q3 FY26 with a 62% jump in cash receipts and a new Mixed Reality sale to the US Department of Defense, underpinning its growing Operator XR platform.

Epiminder has ramped up enrolment in its DETECT study, contracting 18 US medical centres and maintaining a robust $83.8 million cash position to fund its Minder device commercialisation through 2028.

ImpediMed reported a $3.5 million revenue in Q3 FY26, with reimbursement coverage in the US reaching 94.3%, supporting growth in heart health and weight management markets. New CEO Erik Anderson aims to accelerate commercial momentum and drive cash flow break-even.

AVADA Group reported a 14.9% rise in cash receipts for Q1 2026, underpinned by strong sales in Queensland and New South Wales, while completing a refinancing that improves liquidity and covenant headroom.

MPR Australia has no ongoing operations following its $19 million asset sale and is weighing shareholder returns against new business acquisitions amid legacy claims.

Tamboran Resources has closed its retail entitlement offer, adding A$24.8 million to a total equity raise of A$282.6 million to fund expanded drilling and development in the Beetaloo Basin.

Powerhouse Ventures holds $6.14 million in liquid assets and advances new technology fund launch despite challenging market conditions.

Vection Technologies has reported its third straight quarter of positive operating cash flow, driven by a $30 million Defence order book and a surge in AI contracts worth $4 million across multiple sectors.

QPM Energy has secured critical approvals and financing milestones for its 112MW Isaac Power Station, alongside a significant upgrade to its Moranbah Gas Project reserves, positioning it as a key energy supplier in Queensland.

Zinc of Ireland NL is set to reshape its zinc recovery and battery recycling prospects after signing to acquire Meclex's innovative hydrometallurgical technologies and launching a major drilling campaign at its Kildare project.

CurveBeam AI reported stable device orders but faces regulatory delays for FDA and China clearances, while securing a A$4 million investment from WEGO Orthopaedics and advancing clinical collaborations with robotic surgery systems.

Gentrack’s airport technology arm Veovo is acquiring Dubai Technology Partners for US$10 million, boosting its AI portfolio and regional presence in the Middle East.